Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06408649 · ClinicalTrials.gov registry record
Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)
A clinical trial, sponsored by Alcon Research.
- Terminated
- Registry status
- 129
- Enrollment target
NCT06408649 is a clinical trial that was terminated before completion, run by Alcon Research. The registered enrollment target is 129 participants.
The verdict
NCT06408649 was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- 129 participants
- Enrollment target
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices.
Interventions
- DEVICE Lehfilcon A toric contact lenses
- DEVICE Lehfilcon A spherical contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2025-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06408649
The ClinicalTrials.gov registry entry for NCT06408649 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lehfilcon A toric contact lenses is the first listed.
NCT06408649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06408649 about?
NCT06408649 is a clinical study titled "Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices.
What is the current status of trial NCT06408649?
This trial is currently terminated. The enrollment target is 129 participants. The study started on 2024-11-15. Estimated completion is 2025-04-22.
What interventions are being tested in trial NCT06408649?
The interventions under investigation include: Lehfilcon A toric contact lenses (DEVICE), Lehfilcon A spherical contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06408649?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.